MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2018 International Congress

    Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)

    V. Luk, N. Cheung, G. Chan, KF. Leung, NFJ. Lui, WW. Wong, I. Chan, C. Li (Kowloon, Hong Kong)

    Objective: This study aimed to translate and validate a standard Hong Kong Chinese version of the NMSQuest (HK-NMSQuest) to assist in identification of NMS in…
  • 2018 International Congress

    The Reliability Study of King’s Parkinson’s Disease Pain Scale in Indonesian Version

    V. Wijaya, R. Pinzon (Yogyakarta, Indonesia)

    Objective: To create the reliable Indonesian Version of King’s Parkinson’s Disease Pain Scale. Background: Pain is one of the most common non-motor symptoms of Parkinson’s…
  • 2018 International Congress

    Psychosocial Impact of dysarthria: Is speech intelligibility an effective measure outcome?

    C. Atkinson-Clement, A. Letanneux, M. Berthelot, D. Robert, C. Robieux, C. Moreau, G. Baille, A. Eusebio, F. Fluchère, E. Robin, T. Witjas, J.P. Azulay (Aix-en-Provence, France)

    Objective: To identify if intelligibility or social repercussions of dysarthria determined quality of life in patients with different kinds of movement disorders. Background: Dysarthria in…
  • 2018 International Congress

    Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson’s disease with motor fluctuation

    KW. Park, HS. Ryu, MS. Kim, NR. Choi, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the efficacy of levodopa/carbidopa/entacapone (Stalevo®) at bedtime on sleep disturbance in patients with Parkinson’s disease (PD) who have motor fluctuation. Background: Sleep…
  • 2018 International Congress

    Serum Uric Acid Level and Its Relationship to Non-Motor Symptomatology in Parkinson’s disease

    O. Odeniyi, N. Okubadejo, O. Ojo, M. Danesi (Lagos, Nigeria)

    Objective: To determine the relationship between serum uric acid level and non-motor symptoms using the PD specific non-motor symptoms in Nigerian patients with Parkinson’s disease.…
  • 2018 International Congress

    FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease

    R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

    Objective: Develop a patient-reported outcome (PRO) modification of the Functional Rating Scale for pre-Huntington Disease (FuRST-pHD) using focus group, Delphi panel and cognitive pre-testing methodology.…
  • 2018 International Congress

    Annual Clinical Evaluation in Out Patient Clinic May Improve Quality of Life in Patients with Parkinson’s Disease

    M. Tomiyama, T. Ueno (Aomori, Japan)

    Objective: The aim of this study was to examine whether the annual clinical evaluation system improves QOL in Parkinson’s disease (PD) patients. Background: We perform…
  • 2018 International Congress

    Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

    N. Barad, C. Sankhla (Mumbai, India)

    Objective: 1) To study prevalence and clinical characteristics of non-motor symptoms (NMS) in idiopathic parkinson disease (IPD) and atypical Parkinsonism (APD) as compared to age…
  • 2018 International Congress

    Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

    U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)

    Objective: To test the hypothesis that the vagus nerve is measurably atrophic in idiopathic Parkinson’s disease (PD). Background: The vagus nerve is discussed to represent…
  • 2018 International Congress

    Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report

    D. Ciampi-de-Andrade, S. Perez-Lloret, N. Hollenstein, R. Curry, V. Rossetto Barbosa, G. Kägi, S. Hägele-Link, J. Walch, R. Gonzenbach, J-P. Lefaucheur, S. Beer, C. Möller, V. Mylius (Sao Paulo, Brazil)

    Objective: To explore the psychometric properties of the PD-PSS. Background: Evaluating pain in PD patients can be a difficult issue in the everyday clinical practice.…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley